Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) traded down 5.7% during trading on Monday after Truist Financial lowered their price target on the stock from $10.00 to $8.00. Truist Financial currently has a hold rating on the stock. Pediatrix Medical Group traded as low as $6.96 and last traded at $6.98. 507,044 shares traded hands during trading, a decline of 49% from the average session volume of 996,439 shares. The stock had previously closed at $7.40.
MD has been the topic of several other research reports. StockNews.com upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price for the company in a research report on Friday, June 7th. Six research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $8.70.
Check Out Our Latest Stock Report on Pediatrix Medical Group
Institutional Inflows and Outflows
Pediatrix Medical Group Trading Down 5.7 %
The business’s 50-day simple moving average is $7.53 and its two-hundred day simple moving average is $8.67. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $587.37 million, a PE ratio of -8.56, a PEG ratio of 1.47 and a beta of 1.56.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.02. Pediatrix Medical Group had a positive return on equity of 10.31% and a negative net margin of 3.53%. The firm had revenue of $495.10 million during the quarter, compared to the consensus estimate of $496.25 million. On average, analysts predict that Pediatrix Medical Group, Inc. will post 1.13 earnings per share for the current year.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Further Reading
- Five stocks we like better than Pediatrix Medical Group
- What Investors Need to Know About Upcoming IPOs
- Automaker’s Bold Move to an EV Future: Is It Time to Buy Stock?
- Investing in Travel Stocks Benefits
- Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks
- How to Most Effectively Use the MarketBeat Earnings Screener
- Major Gaming Stock to Watch: Why It’s a Safe Bet Now
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.